South San Francisco, CA · Founded 2023 · Privately Held (backing)
Developer of a bispecific antibody therapeutics platform designed for addressing immunology and inflammation. Dualitas Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $87 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $65 million across 1 recorded round; the latest was a $32.6 million early-stage round in Jul 2025.
PMV mark · valuation
$87.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$65.0M
Last round
Early Stage VC
Jul 2025
Team — not yet on record
No current team members for Dualitas Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dualitas Therapeutics with a free account
·Watch Dualitas Therapeutics: the Monday email on marks, rounds and moves
